APA (7th ed.) Citation

AJ, S., V, R., R, L., QM, A., KV, K., ME, R., . . . ZM, Y. (2023). Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis. Journal of hepatology, 79(5), 1110. https://doi.org/10.1016/j.jhep.2023.07.014

Chicago Style (17th ed.) Citation

AJ, Sanyal, et al. "Results from a New Efficacy and Safety Analysis of the REGENERATE Trial of Obeticholic Acid for Treatment of Pre-cirrhotic Fibrosis Due to Non-alcoholic Steatohepatitis." Journal of Hepatology 79, no. 5 (2023): 1110. https://doi.org/10.1016/j.jhep.2023.07.014.

MLA (9th ed.) Citation

AJ, Sanyal, et al. "Results from a New Efficacy and Safety Analysis of the REGENERATE Trial of Obeticholic Acid for Treatment of Pre-cirrhotic Fibrosis Due to Non-alcoholic Steatohepatitis." Journal of Hepatology, vol. 79, no. 5, 2023, p. 1110, https://doi.org/10.1016/j.jhep.2023.07.014.